Dominance of serotype Ia among group B streptococci causing invasive infections in nonpregnant adults in Portugal

Journal of Clinical Microbiology

Volumn 50, Issue 4, 2012, Pages 1219-1227

  Martins, E R ^a   Melo Cristino, J ^a   Ramirez, Mario ^a   Lito, Luís ^b   Monteiro, Lurdes ^b   Martins, Filomena ^c   Pessanha, Maria Ana ^c   Gonçalves, Elsa ^c   Morais, Teresa ^c   Diogo, José ^d   Rodrigues, Ana ^d   Nascimento, Isabel ^e   Ribeiro, Manuela ^f   Cotta, Fernanda ^f   Pinheiro, Dolores ^f   Lopes, Paulo ^g   Calheiros, Ismália ^g   Felício, Luísa ^g   Lameirão, Angelina ^g   Alves, Valquíria ^h   Read, Antónia ^h   Monteiro, Margarida ^h   Castro, Ana Paula ^i,m   Alves, Ana Florinda ^j   Oliveira, Henrique ^j   Mota, Ana Paula ^k   Tomaz, Margarida ^k   Ramalheira, Elmano ⁱ   Bessa, Fernanda ⁱ   Ribeiro, Graça ^l   Boaventura, Luísa ^l   Chaves, Catarina ^l   Reis, Teresa ^l   Ramos, Helena ^m   Ferreira, Susana ^m   Pinto, Paulo ^m   Faustino, Maria Alberta ⁿ   Alves, Adelaide ⁿ   Vaz, Teresa ^o   Gião, Marília ^o   Ferreira, Rui ^o   Fonseca, Ana ^p   Coutinho, Adriana ^p,w   Fonseca, Fernando Augusto ^q   Afonso, Teresa Silva ^r   Canhoto, Nuno ^r   Pina, Teresa ^s   Silvestre, M J ^s   Peres, H ^s   Fontes, Ilse ^t   Martinho, Paulo ^t   Silva, Ana Cristina ^u   Costa, Maria Hermínia ^u   Pinto, Margarida F ^v   Choon, Hermínia ^v   Carvalho, Maria Dinah ^w   Alves, I ^w   Cabral, P ^w   Abecassis, Margarida ^w   Marrão, Gina ^x   Domingos, Ana ^x   Grossinho, José ^x   Cabral, Maria Luísa ^y   Neto, Olga ^y   more..

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

^d HOSPITAL GARCIA DE ORTA   (Portugal)

^e HOSPITAL DE SÃO JOÃO   (Portugal)

^f CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^g HOSPITAL PEDRO HISPANO   (Portugal)

^h Hospital de Vila Real   (Portugal)

ⁱ CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^j Hospital Senhora da Oliveira   (Portugal)

^k Hospital InfanteDomPedro   (Portugal)

^l HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^m HOSPITAL DE BRAGA   (Portugal)

ⁿ HOSPITAL DE FARO   (Portugal)

^o Centro Hospitalar de Cascais   (Portugal)

^p Centro Hospitalar Póvoa do Varzim Vila do Conde   (Portugal)

^q HOSPITAL CENTRAL DO FUNCHAL   (Portugal)

^r HOSPITAL CURRY CABRAL   (Portugal)

^s Hospital de Santa Luzia   (Portugal)

^t Hospital So Sebastio   (Portugal)

^u HOSPITAL DE SANTA MARTA   (Portugal)

^v Hospital do Espirito Santo   (Portugal)

^w HOSPITAL PULIDO VALENTE   (Portugal)

^x Hospital de Santo Andre   (Portugal)

^y Hospital Dos SAMS   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; TETRACYCLINE;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BCA GENE; CONTROLLED STUDY; EPS GENE; ERM(TR) GENE; FEMALE; GENE EXPRESSION PROFILING; GROUP B STREPTOCOCCAL INFECTION; HUMAN; MALE; MULTILOCUS SEQUENCE TYPING; NEWBORN INFECTION; NONHUMAN; PORTUGAL; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SEX RATIO; STREPTOCOCCUS AGALACTIAE; TET(O) GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PORTUGAL; PREGNANCY; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

BOVINAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 84858603460     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05488-11     Document Type: Article

References (62)

1. Altman DG. 1999. Practical statistics for medical research. Chapman &Hall, Boca Raton, FL.
2. Baker CJ, Edwards MS. 2003. Group B streptococcal conjugate vaccines. Arch. Dis. Child. 88:375-378. (Pubitemid 36566714)
3. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. R. Stat Soc. Ser. B Stat. Methodol. 57:289-300.
4. Bergseng H, Rygg M, Bevanger L, Bergh K. 2008. Invasive group B streptococcus (GBS) disease in Norway 1996-2006. Eur. J. Clin. Microbiol. Infect. Dis. 27:1193-1199.
5. Betriu C, et al. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob. Agents Chemother. 47:1112-1114. (Pubitemid 36254242)
6. Blumberg HM, et al. 1996. Invasive group B streptococcal disease: the emergence of serotype V. J. Infect. Dis. 173:365-373. (Pubitemid 26042436)
7. Bohnsack JF, et al. 2008. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J. Clin. Microbiol. 46:1285-1291. (Pubitemid 351563569)
8. Bolaños M, Hernández A, Santana O, Molina J, Martín-Sánchez AA. 2005. Distribution of Streptococcus agalactiae serotypes in samples from non-pregnant adults. Clin. Microbiol. Newsl. 27:151-153.
9. Brzychczy-Wloch M, et al. 2010. Genetic characterization and diversity of Streptococcus agalactiae isolates with macrolide resistance. J. Med. Microbiol. 59:780-786.
10. Buccato S, et al. 2006. Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease. J. Infect. Dis. 194:331-340. (Pubitemid 44116975)
11. Carrico JA, et al. 2006. Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J. Clin. Microbiol. 44:2524-2532. (Pubitemid 44092422)
12. Castor ML, et al. 2008. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect. Dis. Obstet. Gynecol. 2008:727505.
13. Centers for Disease Control and Prevention. 2002. Prevention of perinatal group B streptococcal disease. JAMA 51:1-22.
14. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing - nineteenth informational supplement, vol, no. 3 (M100-S19). Clinical and Laboratory Standards Institute, Wayne, PA.
15. Creti R, Fabretti F, Orefici G, von Hunolstein C. 2004. Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes. J. Clin. Microbiol. 42:1326-1329. (Pubitemid 38332881)
16. Culebras E, Rodriguez-Avial I, Betriu C, Redondo M, Picazo JJ. 2002. Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob. Agents Chemother. 46:1574-1576. (Pubitemid 34415349)
17. DE Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.
18. Diekema DJ, et al. 2003. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J. Clin. Microbiol. 41:2659-2661. (Pubitemid 36712484)
19. Dipersio LP, Dipersio JR. 2007. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus. Diagn. Microbiol. Infect. Dis. 57:189-193.
20. Dogan B, Schukken YH, Santisteban C, Boor KJ. 2005. Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. J. Clin. Microbiol. 43:5899-5906. (Pubitemid 43100635)
21. Domingo P, et al. 1997. Group B streptococcal meningitis in adults: report of twelve cases and review. Clin. Infect. Dis. 25:1180-1187. (Pubitemid 27513207)
22. Edwards MS. 2008. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum. Vaccin. 4:444-448.
23. Farley MM. 2001. Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis. 33:556-561. (Pubitemid 32709591)
24. Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J. 2004. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolideresistant isolates. Microb. Drug Resist. 10:31-36. (Pubitemid 38529714)
25. Fluegge K, Supper S, Siedler A, Berner R. 2004. Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob. Agents Chemother. 48: 4444-4446. (Pubitemid 39434912)
26. Francisco AP, Bugalho M, Ramirez M, Carriço JA. 2009. Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinformatics 10:152.
27. Gherardi G, et al. 2007. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J. Clin. Microbiol. 45:2909-2916. (Pubitemid 47421999)
28. Ip M, et al. 2006. Identification of a Streptococcus agalactiae serotype III subtype 4 clone in association with adult invasive disease in Hong Kong. J. Clin. Microbiol. 44:4252- 4254.
29. Jackson LA, et al. 1995. Risk factors for group B streptococcal disease in adults. Ann. Intern. Med. 123:415- 420.
30. Janapatla RP, Ho YR, Yan JJ, Wu HM, Wu JJ. 2008. The prevalence of erythromycin resistance in group B streptococcal isolates at a University Hospital in Taiwan. Microb. Drug Resist. 14:293-297.
31. Jones N, et al. 2003. Multilocus sequence typing system for group B Streptococcus. J. Clin. Microbiol. 41:2530-2536. (Pubitemid 36712464)
32. Kong F, Gowan S, Martin D, James G, Gilbert GL. 2002. Serotype identification of group B streptococci by PCR and sequencing. J. Clin. Microbiol. 40:216-226. (Pubitemid 34027627)
33. Kothari NJ, et al. 2009. Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007. Emerg. Infect. Dis. 15:1279-1281.
34. Lachenauer CS, et al. 1999. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J. Infect. Dis. 179:1030-1033. (Pubitemid 29159354)
35. Lambertsen L, Ekelund K, Skovsted IC, Liboriussen A, Slotved HC. 2010. Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004. Eur. J. Clin. Microbiol. Infect. Dis. 29:1071-1077.
36. Lin FY, et al. 2006. Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study. J. Clin. Microbiol. 44:1257-1261.
37. Luan SL, et al. 2005. Multilocus sequence typing of Swedish invasive group B Streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J. Clin. Microbiol. 43:3727-3733.
38. Margarit I, et al. 2009. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J. Infect. Dis. 199:108-115.
39. Martins ER, et al. 2011. Group B streptococci causing neonatal infections in Barcelona are a stable clonal population: 18-year surveillance. J. Clin. Microbiol. 49:2911-2918.
40. Martins ER, et al. 2007. Streptococcus agalactiae serotype Ib as an agent of meningitis in two adult nonpregnant women. J. Clin. Microbiol. 45:3850-3852. (Pubitemid 350156904)
41. Martins ER, Melo-Cristino J, Ramirez M. 2010. Evidence for rare capsular switching in Streptococcus agalactiae. J. Bacteriol. 192:1361-1369.
42. Martins ER, Pessanha MA, Ramirez M, Melo-Cristino J, and the Portuguese Group for the Study of Streptococcal Infections. 2007. Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J. Clin. Microbiol. 45:3224-3229. (Pubitemid 47585643)
43. Melo-Cristino J, Fernandes ML. 1999. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. Microb. Drug Resist. 5:219-225. (Pubitemid 29519900)
44. Murayama SY, et al. 2009. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother. 53:2650-2653.
45. Persson E, et al. 2008. Characterisation of invasive group B streptococci based on investigation of surface proteins and genes encoding surface proteins. Clin. Microbiol. Infect. 14:66-73. (Pubitemid 350226573)
46. Persson E, et al. 2004. Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin. Microbiol. Infect. 10:791-796. (Pubitemid 39276312)
47. Phares CR, et al. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:2056-2065. (Pubitemid 351656587)
48. Pinto FR, Melo-Cristino J, Ramirez M. 2008. A confidence interval for the Wallace coefficient of concordance and its application to microbial typing methods. PLoS One 3:e3696.
49. Poyart C, et al. 2008. Invasive group B streptococcal infections in infants, France. Emerg. Infect. Dis. 14:1647-1649.
50. Quentin R, et al. 1995. Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J. Clin. Microbiol. 33:2576-2581.
51. Radtke A, et al. 2009. Identification of surface proteins of group B streptococci: serotyping versus genotyping. J. Microbiol. Methods 78:363-365.
52. Sadowy E, Matynia B, Hryniewicz W. 2010. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland. J. Antimicrob. Chemother. 65:1907-1914.
53. Sambola A, et al. 2002. Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998. Clin. Infect. Dis. 34:1576-1584. (Pubitemid 34615442)
54. Schrag SJ, et al. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342:15-20. (Pubitemid 30020655)
55. Schuchat A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513. (Pubitemid 28379097)
56. Silva-Costa C, Pinto FR, Ramirez M, Melo-Cristino J. 2008. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Clin. Microbiol. Infect. 14:1152-1159.
57. Skoff TH, et al. 2009. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin. Infect. Dis. 49:85-92.
58. Trzcinski K, Cooper BS, Hryniewicz W, Dowson CG. 2000. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 45:763-770. (Pubitemid 30348944)
59. Tsai JC, et al. 2005. The erm(T) gene is flanked by IS1216V in inducible erythromycin-resistant Streptococcus gallolyticus subsp. pasteurianus. Antimicrob. Agents Chemother. 49:4347- 4350.
60. Uh Y, et al. 2004. Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea. J. Clin. Microbiol. 42:3306-3308. (Pubitemid 38938099)
61. von Both U, et al. 2003. A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J. Clin. Microbiol. 41:2166-2169.
62. Zhao Z, et al. 2008. Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups. Clin. Microbiol. Infect. 14:260-267. (Pubitemid 351201017)